Inhaler Corticosteroid Device Global Market Report 2025
상품코드:1810921
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
흡입 코르티코스테로이드 디바이스 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 6.6%로 217억 7,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장의 원동력은 호흡기 질환 증가, 호흡기 건강에 대한 인식 증가, 호흡기 기술에 대한 막대한 투자, 건강 교육에 대한 관심 확대, 흡연 중독 증가입니다. 이 기간 중 영향을 미칠 것으로 예상되는 주요 동향으로는 스마트 기술 채택, 병용요법 개발, 실시간 모니터링이 가능한 디지털 흡입기 도입, 흡입기 설계의 발전, 흡입기 장치에서 데이터 분석 활용 등이 있습니다.
호흡기 질환의 유병률 증가는 향후 수년간 흡입 코르티코스테로이드 장치 시장의 성장을 가속할 것으로 예측됩니다. 호흡기 질환에는 적절하고 효율적인 호흡을 방해하는 폐와 기도에 영향을 미치는 다양한 질환이 포함됩니다. 호흡기 질환 증가는 폐 조직을 손상시키고 천식, 기관지염과 같은 만성질환을 유발하는 유해한 입자에 사람들을 노출시키는 대기 오염 증가에 기인합니다. 흡입식 코르티코스테로이드 장치는 항염증약를 폐에 직접 주입하여 호흡기 질환을 치료하고 염증을 억제하여 호흡을 개선하는 데 도움을 줍니다. 예를 들어 2025년 6월 영국 보건 개선 및 격차 대책국은 2024 회계연도에 영국에서 호흡기 질환으로 인한 응급 입원이 85만 4,922건, 인구 10만 명당 1,428건(1,424건에서 1,432건 범위)으로 전년 대비 7% 증가했다고 보고했습니다. 이 때문에 호흡기 질환의 유병률 증가는 흡입형 코르티코스테로이드 장치 시장의 성장을 가속하고 있습니다.
흡입형 코르티코스테로이드 기기 시장의 주요 기업은 알부테롤과 부데소니드를 결합한 레스큐 흡입기와 같은 혁신적인 솔루션 출시에 주력하고 있으며, 치료 효과를 개선하고 환자에게 하나의 기기로 보다 편리한 이중 작용 치료를 제공하기 위해 노력하고 있습니다. 알부테롤과 부데소니드 복합 흡입기는 기관지확장제(알부테롤)로 기도를 빠르게 열고 코르티코스테로이드(부데소니드)로 염증을 억제하는 이중 작용 구조 흡입기로, 하나의 흡입기로 빠른 증상 완화와 장기적인 천식 조절을 제공합니다. 예를 들어 2024년 1월 영국 제약회사 아스트라제네카(AstraZeneca PLC)는 성인 천식 환자를 위해 알부테롤과 부데소니드를 결합한 최초이자 유일한 FDA 승인 구조용 흡입기인 에어수프라(AIRSUPRA)를 출시했습니다. 이 흡입제는 급성 기관지 수축 증상을 완화하고 기도의 염증을 억제하여 심각한 천식 발작의 위험을 낮추기 위해 필요에 따라 사용하는 것을 목적으로 합니다. 단시간 작용형 베타2 작용제(알부테롤)와 흡입용 코르티코스테로이드(부데소니드)를 하나의 흡입기에 결합한 새로운 접근방식으로, 천식 악화 예방에 있으며, 알부테롤 단독보다 우수한 효과를 입증한 임상시험을 바탕으로 승인되었습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 흡입 코르티코스테로이드 디바이스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 흡입 코르티코스테로이드 디바이스 시장 : 성장률 분석
세계의 흡입 코르티코스테로이드 디바이스 시장 실적 : 규모와 성장, 2019-2024
세계의 흡입 코르티코스테로이드 디바이스 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 흡입 코르티코스테로이드 디바이스 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 흡입 코르티코스테로이드 디바이스 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
정량 흡입기
드라이 파우더 흡입기
소프트 미스트 흡입기
세계의 흡입 코르티코스테로이드 디바이스 시장 : 처방 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
Fluticasone Propionate
Budesonide
Beclomethasone
Mometasone Furoate
세계의 흡입 코르티코스테로이드 디바이스 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
온라인 약국
소매 약국
직접 판매
병원 약국
세계의 흡입 코르티코스테로이드 디바이스 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
천식
만성폐쇄성폐질환(COPD)
기타 용도
세계의 흡입 코르티코스테로이드 디바이스 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
홈케어
전문 클리닉
기타 최종사용자
세계의 흡입 코르티코스테로이드 디바이스 시장 : 서브 세분화, 정량 분무식 흡입기(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
기존 정량 흡입기
호흡 작동식 정량 흡입기
스페이서 일체형 정량 흡입기
세계의 흡입 코르티코스테로이드 디바이스 시장 : 서브 세분화, 드라이 파우더 흡입기(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
단회투여 드라이 파우더 흡입기
다회투여 드라이 파우더 흡입기
리저버 드라이 파우더 흡입기
세계의 흡입 코르티코스테로이드 디바이스 시장 : 서브 세분화, 소프트 미스트 흡입기(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
수동 소프트 미스트 흡입기
배터리식 소프트 미스트 흡입기
제7장 지역별·국가별 분석
세계의 흡입 코르티코스테로이드 디바이스 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 흡입 코르티코스테로이드 디바이스 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
흡입 코르티코스테로이드 디바이스 시장 : 경쟁 구도
흡입 코르티코스테로이드 디바이스 시장 : 기업 개요
AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Teijin Pharma Limited
Sun Pharmaceutical Industries Limited
Aurobindo Pharma Limited
Chiesi Farmaceutici S.p.A.
Cipla Limited
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals Inc.
Mundipharma International Limited
Lupin Limited
Zydus Lifesciences Limited
Recipharm AB
Glenmark Pharmaceuticals Limited
Orion Corporation
Beximco Pharmaceuticals Limited
PARI Medical Holding GmbH
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
흡입 코르티코스테로이드 디바이스 시장 2029 : 새로운 기회를 제공하는 국가
흡입 코르티코스테로이드 디바이스 시장 2029 : 새로운 기회를 제공하는 부문
흡입 코르티코스테로이드 디바이스 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
An inhaler corticosteroid device is a specialized medical instrument designed to deliver anti-inflammatory corticosteroid medication directly into the lungs. This targeted delivery reduces swelling and irritation in the airways caused by chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). By acting locally in the lungs, these devices help control and prevent symptoms like wheezing, shortness of breath, and coughing, while limiting the systemic side effects often associated with oral corticosteroids.
The primary types of inhaler corticosteroid devices include metered-dose inhalers, dry powder inhalers, and soft mist inhalers. Metered-dose inhalers (MDIs) are portable devices that release a precise, measured dose of medication into the lungs as an aerosol. These inhalers use various drug formulations such as fluticasone propionate, budesonide, beclomethasone, and mometasone furoate. They are distributed through online and retail pharmacies, direct sales, and hospital pharmacies. These devices are widely used for managing conditions like asthma and COPD, with end users including hospitals, home care providers, specialty clinics, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The inhaler corticosteroid device market research report is one of a series of new reports from The Business Research Company that provides inhaler corticosteroid device market statistics, including inhaler corticosteroid device industry global market size, regional shares, competitors with an inhaler corticosteroid device market share, detailed inhaler corticosteroid device market segments, market trends and opportunities, and any further data you may need to thrive in the inhaler corticosteroid device industry. This inhaler corticosteroid device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The inhaler corticosteroid device market size has grown strongly in recent years. It will grow from $15.75 billion in 2024 to $16.83 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period was driven by rising healthcare spending, a growing elderly population, favorable government policies, ongoing research and development efforts, and higher disposable incomes.
The inhaler corticosteroid device market size is expected to see strong growth in the next few years. It will grow to $21.77 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during the forecast period is driven by an increase in respiratory disorders, heightened awareness of respiratory health, substantial investments in respiratory technologies, an expanding focus on health education, and a rise in smoking addiction. Key trends expected to influence this period include the adoption of smart technologies, development of combination therapies, introduction of digital inhalers with real-time monitoring, advancements in inhaler design, and the use of data analytics in inhaler devices.
The rising prevalence of respiratory diseases is expected to drive the growth of the inhaler corticosteroid device market in the coming years. Respiratory diseases encompass a variety of conditions affecting the lungs and airways, which impair proper and efficient breathing. The increase in respiratory diseases is attributed to growing air pollution, exposing people to harmful particles that damage lung tissue and trigger chronic conditions such as asthma and bronchitis. Inhaler corticosteroid devices treat respiratory diseases by delivering anti-inflammatory medication directly to the lungs, helping to reduce inflammation and improve breathing. For example, in June 2025, the UK's Office for Health Improvement and Disparities reported that in the financial year ending 2024, England recorded 854,922 emergency hospital admissions for respiratory diseases, corresponding to a rate of 1,428 (ranging from 1,424 to 1,432) per 100,000 population-a 7% increase compared to the previous year. Therefore, the growing prevalence of respiratory diseases is fueling the expansion of the inhaler corticosteroid device market.
Leading companies in the inhaler corticosteroid device market are focusing on launching innovative solutions, such as rescue inhalers that combine albuterol and budesonide to improve treatment efficacy and provide patients with a more convenient, dual-action therapy within a single device. An inhaler combining albuterol and budesonide is a dual-action rescue inhaler that delivers both a bronchodilator (albuterol) to rapidly open airways and a corticosteroid (budesonide) to reduce inflammation, offering quick symptom relief and long-term asthma control in one device. For instance, in January 2024, AstraZeneca PLC, a UK-based pharmaceutical company, introduced AIRSUPRA, the first and only FDA-approved rescue inhaler combining albuterol and budesonide for adults with asthma. This inhaler is intended for as-needed use to relieve acute bronchoconstriction symptoms and reduce airway inflammation, thereby lowering the risk of severe asthma attacks. It represents a novel approach by combining a short-acting beta2-agonist (albuterol) with an inhaled corticosteroid (budesonide) in a single inhaler, with approval based on clinical trials demonstrating its superiority over albuterol alone in preventing asthma exacerbations.
In March 2022, Sandoz Group AG, a Switzerland-based company specializing in generic pharmaceuticals and biosimilars, acquired Coalesce Product Development Limited for an undisclosed amount. This acquisition aims to strengthen Sandoz's position in developing and delivering complex, high-quality respiratory therapies by incorporating Coalesce's advanced expertise in innovative drug delivery device design and manufacturing. This supports Sandoz's broader strategy to expand its value-added medicines portfolio and reinforce its commitment to patient-focused, integrated treatment solutions. Coalesce Product Development Limited is a UK-based medical device company specializing in designing and developing respiratory drug delivery devices, including inhalers for inhaled corticosteroids.
Major players in the inhaler corticosteroid device market are AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Teijin Pharma Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Mundipharma International Limited, Lupin Limited, Zydus Lifesciences Limited, Recipharm AB, Glenmark Pharmaceuticals Limited, Orion Corporation, Beximco Pharmaceuticals Limited, PARI Medical Holding GmbH, and Kos Pharmaceuticals Inc.
North America was the largest region in the inhaler corticosteroid device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inhaler corticosteroid device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the inhaler corticosteroid device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The inhaler corticosteroid device market consists of sales of nebulizer solutions, manual soft mist inhalers, conventional metered-dose inhalers, and combination inhalers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Inhaler Corticosteroid Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on inhaler corticosteroid device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for inhaler corticosteroid device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The inhaler corticosteroid device market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Inhaler Corticosteroid Device Market Trends And Strategies
4. Inhaler Corticosteroid Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Inhaler Corticosteroid Device Growth Analysis And Strategic Analysis Framework
5.1. Global Inhaler Corticosteroid Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Inhaler Corticosteroid Device Market Growth Rate Analysis
5.4. Global Inhaler Corticosteroid Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Inhaler Corticosteroid Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Inhaler Corticosteroid Device Total Addressable Market (TAM)
6.1. Global Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metered-Dose Inhalers
Dry Powder Inhalers
Soft Mist Inhalers
6.2. Global Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluticasone Propionate
Budesonide
Beclomethasone
Mometasone Furoate
6.3. Global Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online Pharmacies
Retail Pharmacies
Direct Sales
Hospital Pharmacies
6.4. Global Inhaler Corticosteroid Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Other Applications
6.5. Global Inhaler Corticosteroid Device Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End-Users
6.6. Global Inhaler Corticosteroid Device Market, Sub-Segmentation Of Metered-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional Metered-Dose Inhalers
Breath-Actuated Metered-Dose Inhalers
Spacer-Integrated Metered-Dose Inhalers
6.7. Global Inhaler Corticosteroid Device Market, Sub-Segmentation Of Dry Powder Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Dose Dry Powder Inhalers
Multi-Dose Dry Powder Inhalers
Reservoir Dry Powder Inhalers
6.8. Global Inhaler Corticosteroid Device Market, Sub-Segmentation Of Soft Mist Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Manual Soft Mist Inhalers
Battery-Operated Soft Mist Inhalers
7. Inhaler Corticosteroid Device Market Regional And Country Analysis
7.1. Global Inhaler Corticosteroid Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Inhaler Corticosteroid Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Inhaler Corticosteroid Device Market
9.1. China Inhaler Corticosteroid Device Market Overview
9.2. China Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Inhaler Corticosteroid Device Market
10.1. India Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Inhaler Corticosteroid Device Market
11.1. Japan Inhaler Corticosteroid Device Market Overview
11.2. Japan Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Inhaler Corticosteroid Device Market
12.1. Australia Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Inhaler Corticosteroid Device Market
13.1. Indonesia Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Inhaler Corticosteroid Device Market
14.1. South Korea Inhaler Corticosteroid Device Market Overview
14.2. South Korea Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Inhaler Corticosteroid Device Market
15.1. Western Europe Inhaler Corticosteroid Device Market Overview
15.2. Western Europe Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Inhaler Corticosteroid Device Market
16.1. UK Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Inhaler Corticosteroid Device Market
17.1. Germany Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Inhaler Corticosteroid Device Market
18.1. France Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Inhaler Corticosteroid Device Market
19.1. Italy Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Inhaler Corticosteroid Device Market
20.1. Spain Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Inhaler Corticosteroid Device Market
21.1. Eastern Europe Inhaler Corticosteroid Device Market Overview
21.2. Eastern Europe Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Inhaler Corticosteroid Device Market
22.1. Russia Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Inhaler Corticosteroid Device Market
23.1. North America Inhaler Corticosteroid Device Market Overview
23.2. North America Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Inhaler Corticosteroid Device Market
24.1. USA Inhaler Corticosteroid Device Market Overview
24.2. USA Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Inhaler Corticosteroid Device Market
26.1. South America Inhaler Corticosteroid Device Market Overview
26.2. South America Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Inhaler Corticosteroid Device Market
27.1. Brazil Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Inhaler Corticosteroid Device Market
28.1. Middle East Inhaler Corticosteroid Device Market Overview
28.2. Middle East Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Inhaler Corticosteroid Device Market
29.1. Africa Inhaler Corticosteroid Device Market Overview
29.2. Africa Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Inhaler Corticosteroid Device Market Competitive Landscape And Company Profiles
